gamma-thiobutyrolactone has been researched along with Kidney Failure, Chronic in 1 studies
*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Fattah, MA; Khan, JA; Zohny, SF | 1 |
1 other study(ies) available for gamma-thiobutyrolactone and Kidney Failure, Chronic
| Article | Year |
|---|---|
Circulating Fibroblast Growth Factor-23 Level and Paraoxonase-1 Lactonase Activity in Chronic Hemodialysis Patients: Their Impact on the Incidence of Native AV Fistula Thrombosis.
Topics: 4-Butyrolactone; Adult; Aged; Arteriovenous Fistula; Aryldialkylphosphatase; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Thrombosis | 2016 |